Related Experiment Video
Updated: Jul 9, 2025
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Amyloid-β1-42 oligomers enhance mGlu5R-dependent synaptic weakening via NMDAR activation and complement C5aR1
Ai Na Ng1, Eric W Salter2,3, John Georgiou2,4
1School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.
Abstract:
Synaptic weakening and loss are well-correlated with the pathology of Alzheimer's disease (AD). Oligomeric amyloid beta (oAβ) is considered a major synaptotoxic trigger for AD. Recent studies have implicated hyperactivation of the complement cascade as the driving force for loss of synapses caused by oAβ. However, the initial synaptic cues that trigger pathological complement activity remain elusive. Here, we examined a form of synaptic long-term depression (LTD) mediated by metabotropic glutamate receptors (mGluRs) that is disrupted in rodent models of AD. Exogenous application of oAβ (1-42) to mouse hippocampal slices enhanced the magnitude of mGlu subtype 5 receptor (mGlu5R)-dependent LTD. We found that the enhanced synaptic weakening occurred via both N-methyl-D-aspartate receptors (NMDARs) and complement C5aR1 signaling. Our findings reveal a mechanistic interaction between mGlu5R, NMDARs, and the complement system in aberrant synaptic weakening induced by oAβ, which could represent an early trigger of synaptic loss and degeneration in AD.
Insights
Oligomeric amyloid beta triggers Alzheimer's disease synaptic loss by activating complement pathways. This study reveals how metabotropic glutamate receptors and N-methyl-D-aspartate receptors interact with the complement system to drive aberrant synaptic weakening.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Synaptic weakening and loss are hallmarks of Alzheimer's disease (AD) pathology.
- Oligomeric amyloid beta (oAβ) is a key synatotoxic agent in AD.
- Hyperactivation of the complement cascade is implicated in oAβ-induced synapse loss, but initial triggers are unknown.
Purpose of the Study:
- To investigate the synaptic mechanisms underlying oAβ-induced synaptic dysfunction.
- To identify the initial synaptic cues that trigger pathological complement activity in AD.
Main Methods:
- Utilized mouse hippocampal slices to study synaptic long-term depression (LTD).
- Applied exogenous oAβ (1-42) to slices.
- Examined the roles of metabotropic glutamate receptors (mGluRs), N-methyl-D-aspartate receptors (NMDARs), and complement C5aR1 signaling.
Main Results:
- oAβ application enhanced mGlu subtype 5 receptor (mGlu5R)-dependent LTD.
- This enhanced synaptic weakening involved both NMDARs and complement C5aR1.
- A mechanistic link between mGlu5R, NMDARs, and complement signaling in oAβ-induced synaptic changes was identified.
Conclusions:
- Aberrant synaptic weakening induced by oAβ involves an interaction between mGlu5R, NMDARs, and the complement system.
- This interaction may represent an early trigger for synaptic loss and neurodegeneration in Alzheimer's disease.
